Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Instant MSC Product Accompanying Autologous Chondron Transplantation (IMPACT): Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.

NCT02037204 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT02037204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02037204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Instant MSC Product Accompanying Autologous Chondron Transplantation (IMPACT): Safety and Feasibility of a Single-stage Procedure for Focal Cartilage Lesions of the Knee.
Lead sponsor
UMC Utrecht
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2013
Completion date
April 30, 2016
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effusion (l) knee, foreign-body reaction, inflammation, knee pain swelling